Last update 02 May 2024
BELLUS Health, Inc.

BELLUS Health, Inc.

Public Company | Subsidiary Company|
1993|
Quebec, Canada
|
100-250
| TSX: BLU|

Overview

Basic Info

Introduction
BELLUS Health is dedicated to creating drugs for uncommon medical conditions, with a focus on those affecting the kidneys. Their primary project, KIACTA, is a novel drug candidate that has completed Phase 3 trials for the treatment of AA amyloidosis. The company has partnered with Auven Therapeutics for the development of this drug. Additionally, KIACTA is being developed for sarcoidosis, a potentially fatal inflammatory disease that impacts the lungs. BELLUS Health is also working on Shigamab, an antibody treatment for Hemolytic Uremic Syndrome caused by Shiga toxin-producing E. coli, which can result in kidney damage and even death. They are also researching a treatment for AL amyloidosis, a rare disease in which amyloid protein accumulates and causes dysfunction throughout the body.

Tags

Congenital Disorders
Nervous System Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug2

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
1
Phase 3 Clinical
Other
8
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free